Bioinformatics workflows for genomic analysis of tumors from Patient Derived Xenografts (PDX): challenges and guidelines
Xing Yi WooiD, Anuj SrivastavaiD, Joel H. GraberiD, Vinod Kumar YadaviD, Vishal SarsaniiD, Al Simons, Glen Beane, Stephen C. GrubbiD, Guruprasad AnandaiD, Rangjiao Liu, Grace A. StaffordiD, Jeffrey H. ChuangiD, Susan D. AirhartiD, Radha Krishna Murthy KaruturiiD, Joshy GeorgeiD, Carol J. BultiD
Abstract
Bioinformatics workflows for analyzing genomic data obtained from xenografted tumor (e.g., human tumors engrafted in a mouse host) must address several challenges, including separating mouse and human sequence reads and accurate identification of somatic mutations and copy number aberrations when paired normal DNA from the patient is not available. We report here data analysis workflows that address these challenges and result in reliable identification of somatic mutations, copy number alterations, and transcriptomic profiles of tumors from patient derived xenograft models. We validated our analytical approaches using simulated data and by assessing concordance of the genomic properties of xenograft tumors with data from primary human tumors in The Cancer Genome Atlas (TCGA). The commands and parameters for the workflows are available at https://github.com/TheJacksonLaboratory/PDX-Analysis-Workflows.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 48
- FWCI
- 2.76
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis
Y. A. Evrard, A. SRIVASTAVA, … J. Morris·bioRxiv·Oct 2, 2019
- Integrative Pharmacogenomics Analysis of Patient Derived Xenografts
Arvind Singh Mer, Wail Ba-Alawi, … Benjamin Haibe‐Kains·Cancer ResearchPeer-reviewed·May 29, 2019
- SMAP: exploiting high-throughput sequencing data of patient derived xenografts
Yuna Blum, Aurélien de Reyniès, … Rémy Nicolle·bioRxiv·Oct 11, 2018
- Patient-derived xenografts undergo murine-specific tumor evolution
U. Ben-David, G. Ha, … T. R. Golub·bioRxiv·Jul 24, 2017
- DNA-based copy number analysis confirms genomic evolution of PDX models
A. Hoge, M. Getz, … U. Ben-David·bioRxiv·Jan 15, 2021
- Analysis of patient derived xenograft studies in Oncology drug development: impact on design and interpretation of future studies
Jake Dickinson, Marcel de Matas, … Hitesh Mistry·bioRxiv·Mar 15, 2019